Literature DB >> 4391090

The negative inotropic effect of adrenergic betareceptor blocking drugs on human heart muscle.

W G Nayler, D Chipperfield, T E Lowe.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4391090     DOI: 10.1093/cvr/3.1.30

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


× No keyword cloud information.
  11 in total

1.  Clinical evaluation of oxprenolol in angina pectoris.

Authors:  G Sandler; A Pistevos
Journal:  Br Heart J       Date:  1972-08

2.  The pharmacokinetics and metabolism of Kö592 in man, dog and rat.

Authors:  D Arndts; W Pollmann
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

3.  [The effect of 1-(isopropylamino)-3-(m-toyloxy)-2-propanol hydrochloride (Doberol) on the bronchial system after oral administration].

Authors:  W Günthner
Journal:  Eur J Clin Pharmacol       Date:  1972-06       Impact factor: 2.953

4.  The effects of three beta-adrenoceptor blocking drugs on isolated preparations of skeletal and cardiac muscle.

Authors:  J D Harry; R J Linden; H M Snow
Journal:  Br J Pharmacol       Date:  1974-10       Impact factor: 8.739

5.  Use of oxprenolol in cardiac arrhythmias associated with acute myocardial ischaemia.

Authors:  G Sandler; A C Pistevos
Journal:  Br Med J       Date:  1971-01-30

6.  Beta-adrenoceptor blockade and atrio-ventricular conduction in dogs. Role of intrinsic sympathomimetic activity.

Authors:  J F Giudicelli; F Lhoste
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

7.  Comparative chronotropic activity of beta-adrenoceptive antagonists.

Authors:  A M Barrett; J Carter
Journal:  Br J Pharmacol       Date:  1970-11       Impact factor: 8.739

8.  Pharmacology of AH 5158; a drug which blocks both - and -adrenoceptors.

Authors:  J B Farmer; I Kennedy; G P Levy; R J Marshall
Journal:  Br J Pharmacol       Date:  1972-08       Impact factor: 8.739

Review 9.  Time and technology will tell: the pathophysiologic basis of neurohormonal modulation in heart failure.

Authors:  Brent N Reed; Sarah E Street; Brian C Jensen
Journal:  Heart Fail Clin       Date:  2014-08-14       Impact factor: 3.179

10.  Protection against adrenochrome-induced myocardial damage by various pharmacological interventions.

Authors:  J C Yates; G M Taam; P K Singal; R E Beamish; N S Dhalla
Journal:  Br J Exp Pathol       Date:  1980-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.